PMID: 11901911Mar 21, 2002Paper

Building a better therapy for stage IIIA non-small cell lung cancer

Clinics in Chest Medicine
Tracey L EvansThomas J Lynch

Abstract

What do clinicians know about stage IIIA lung cancer? They know accurate staging is critical and requires wide application of mediastinoscopy. They know that surgery and radiation alone each can cure a small subset of patients, and complete resection is of the utmost importance in surgically treated patients. They know that chemotherapy can increase the number of patients cured when combined with definitive radiation, and concurrent chemoradiotherapy seems superior to sequential. Neoadjuvant chemotherapy also seems to cure more patients than surgery alone, but more data are necessary. Trimodality therapy remains a promising but unproved approach in patients with stage IIIA disease. With the exciting new molecularly targeted agents, trials examining quad-modality therapy are just around the corner.

References

Feb 20, 1992·The New England Journal of Medicine·C Schaake-KoningA Nijs
Jan 1, 1992·Journal of the National Cancer Institute·T Le ChevalierJ Y Douillard
Jun 1, 1992·The Annals of Thoracic Surgery·H I PassJ Minna
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M G TrovóC Gobitti
Feb 1, 1991·The Annals of Thoracic Surgery·Y WatanabeT Takashima
Jun 1, 1991·The Annals of Thoracic Surgery·M S AllenA D Hilgenberg
May 1, 1989·The Annals of Thoracic Surgery·L P FaberM S Lee
Mar 1, 1988·European Journal of Cancer & Clinical Oncology·K MattsonE Nordman
Nov 27, 1986·The New England Journal of Medicine·UNKNOWN Lung Cancer Study Group
Feb 1, 1987·The Annals of Thoracic Surgery·G A PattersonJ D Cooper
Jun 16, 1993·Journal of the National Cancer Institute·A GregorH H Hansen
Jan 1, 1995·The Annals of Thoracic Surgery·J R IzbickiO Thetter
Jun 1, 1997·The Annals of Thoracic Surgery·F C Detterbeck
Jul 1, 1997·The European Respiratory Journal·A GdeedoE Van Marck
Mar 11, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J F VansteenkisteM G Demedts
Jul 27, 1999·The Annals of Thoracic Surgery·R J DowneyR J Ginsberg
Sep 4, 1999·The Annals of Thoracic Surgery·J R SonettZ Gamliel
Oct 27, 1999·The Journal of Thoracic and Cardiovascular Surgery·Z T HammoudG A Patterson
Nov 26, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·R RosellJ Roig
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·Q F FengW B Yin
Jul 27, 2000·The New England Journal of Medicine·R M PietermanH J Groen

❮ Previous
Next ❯

Citations

Feb 21, 2006·Physical Review Letters·G LeafM Grimsditch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.